Slide 1: Investor Presentation
Investor Presentation Equity Forum Fall Conference 06 – 07 September 2021 Blue Cap AG
Slide 2: Agenda
Agenda 01_ Overview 02_ Business Performance 03_ Financial Performance H1 2021 04_ Appendix
Slide 3: 01_ Overview
01_ Overview
Slide 4: Blue Cap at a Glance
Blue Cap at a Glance Portfolio of 10 companies Listed Private Equity company with our latest acquisition with investment focus on HY-LINE German-speaking SME companies with clear potential for active transformation Primarily control investments Sales of EUR 233 mn Our business model and EBITDA adj.
Slide 5: High Value Diversification across Sectors
High Value Diversification across Sectors Coating Production Technology Technology Invest: 2016 / 100% Invest: 2014 / 90% Invest: 2011 / 100% Revenue: € 55 mn Employees: 263 28% Revenue: € 2 mn Employees: 23 Revenue: € 7 mn Employees: 37 2% Plastics Electronics Technology Acquired in Invest: 2019 /
Slide 6: Experienced Management Team with Complementary Skills
Experienced Management Team with Complementary Skills Tobias Hoffmann-Becking Ulrich Blessing Matthias Kosch Chief Investment Officer Chief Operating Officer Chief Financial Officer Main Responsibilities Main Responsibilities Main Responsibilities ▪ M&A Business ▪ Portfolio Management ▪ Finance and
Slide 7: Our Focus: Companies with Core Business in Production, Distribution or Services of Industrial Goods
Our Focus: Companies with Core Business in Production, Distribution or Services of Industrial Goods Investment Investment Situations Criteria Succession Revenue from EUR 30 to 80 mn Equity between Headquarters Carve-out EUR 5 and 25 mn DACH Potential for growth Growth challenges and operational impr
Slide 8: BUY: Active Market Screening to Realize 1-2 Acquisitions Every Year
BUY: Active Market Screening to Realize 1-2 Acquisitions Every Year plus Add-On Acquisitions Annual Deal Flow Direct M&A Contacts Advisors Investment Banks 20% Initial approach ~ 200 37,5% Detailed analysis ~40 Identification of value Due diligence creation levers and 30% ~15 transformation potentia
Slide 9: TRANSFORM: Active and Strategic Support
TRANSFORM: Active and Strategic Support Boost growth Encourage sustainability Launch initiatives Reduce portfolio risks Drive digitalization Relieve balance sheets Develop & implement individual strategies and autonomous management Blue Cap AG _ Investor Presentation 9
Slide 10: SELL: Realising the Value Created
SELL: Realising the Value Created “Best Owner” Approach Buy, Buy,Turnaround, Sell Turnaround, Sell ▪ We keep our portfolio companies as long as we are the “Best Owner”, and value creation is still possible with Blue Cap as main shareholder ▪ When our full potential is realized we actively look for t
Slide 11: SELL: Business Model is Confirmed by Our Exits
SELL: Business Model is Confirmed by Our Exits em-tec WISAP Biolink Medical Technology Medical Technology Adhesive Technology ▪ Investment: 2014 ▪ Investment: 2012 ▪ Investment: 2009 ▪ Exit: 2020 ▪ Exit: 2018 ▪ Exit: 2017 ▪ Buyer: Dover Corp. (Illinois, USA) ▪ Buyer: Aouha (Shanghai, China) ▪ Buyer:
Slide 12: 02_ Business Performance
Business 02_ Performance
Slide 13: Milestones 2020/2021 Extensive Portfolio Transformation
Milestones 2020/2021 Extensive Portfolio Transformation ▪ Increased presence in capital markets and intensified investor relations Capital ▪ New annual report with increased information and more transparancey Markets ▪ Capital increase by 10% in August 2021 ▪ Insolvency of SMB-David in June 2020 Leg
Slide 14: HY-LINE: A Specialist for Complex Electronic Components
HY-LINE: A Specialist for Complex Electronic Components Value Chain Concept phase Pre-series Procurement Shipping Distribution Design-in phase Delivery phase ▪ Established value-added (development, 1-2 yrs.) (over model life-time, 5-15 yrs.) distributor that acts as a full- service provider for elec
Slide 15: HY-LINE: End-Market Trends Show a Favorable Long-Term Market Environment
HY-LINE: End-Market Trends Show a Favorable Long-Term Market Environment Overview of Selected Market Trends and Growth Drivers Driver Description Rele- Past Future vance impact impact Health care ▪ The market has been steadily increasing in the past and this trend is expected to continue in the futu
Slide 16: HY-LINE: Long-Term Growth Trend Intact, Rebound in Orders after Cyclical Decline
HY-LINE: Long-Term Growth Trend Intact, Rebound in Orders after Cyclical Decline Distribution of Electronic Components Incoming Orders and Sales per Quarter in € bn. in € bn. +62,2% Order intake Sales 1.239 +21,7% 833 822 764 682 709 711 617 628 631 Q1/2020 Q2/2020 Q3/2020 Q4/2020 Q1/2021 The indust
Slide 17: HY-LINE: Attractive Financial Profile and Various Value Creation Opportunities
HY-LINE: Attractive Financial Profile and Various Value Creation Opportunities Order Backlog Development Value Creation Opportunities ▪ Continued transformation to increase value add and share of own products 162% 170% 142% 153% 135% 119% 100% ▪ Rebound in demand (ongoing) Jan 21 Feb 21 March 21 Apr
Slide 18: 03_ Financial Performance H1 2021
Financial Performance 03_ H1 2021
Slide 19: Good Start into 2021
Good Start into 2021 Performance in H1 2021 Significantly Improved Profitability ▪ Sales and EBITDA increased which is mainly due to the 120.8 acquisition of the Hero Group, the expansion of the Revenue (€ mn) +6% packaging business at con-pearl and a positive 113.9 development of Planatol. 10.5 ▪ S
Slide 20: NAV: Substantial Portfolio Value with Growth Potential
NAV: Substantial Portfolio Value with Growth Potential Net Asset Value as of 30 June 2021 In EUR mn 155.2 -1.9 9.2 +12% 29.1 Indicative 118.8 NAV per 138.5 share (*) € 38.82 Plastics Technology 56.9 Indicative NAV per share € 34.68 Coating Technology 42.8 Adhesive Technologie Metal Technology 12.5 P
Slide 21: Attractive Dividend Policy
Attractive Dividend Policy Dividend per Share and Dividend Yield(1) Stable Dividend In EUR and in % ▪ Blue Cap AG targets a stable base dividend over the cycle 4.7% 4.5% 5.6% 1.00 Increases ▪ Over time with a growing portfolio basedividend shall 0.25 increase 0.75 0.75 ▪ Special dividends from succe
Slide 22: Outlook: We Have Ambitious Targets
Outlook: We Have Ambitious Targets Further Strengthen the Portfolio Structure Short Term Goals ▪ Short term financial goal for 2021: Sales of Successful organic development EUR 265-275 mn and EBITDA (adj.) margin of 8-9% Growth by acquiring new companies ▪ Net debt/EBITDA adj. ≤ 2.75 Inorganic growt
Slide 23: Contact
Contact Tobias Hoffmann-Becking Board Member M&A / Capital Markets hoffmann-becking@blue-cap.de +49 89 288909-10 Blue Cap AG Ludwigstraße 11 office@blue-cap.de 80539 München www.blue-cap.de
Slide 24: 04_ Appendix
04_ Appendix
Slide 25: Financial Calendar 2021
Financial Calendar 2021 Date Event Location 06 – 07 September 2021 Equity Forum Fall Conference Virtual 22 – 24 November 2021 Deutsches Eigenkapitalforum Virtual Blue Cap AG _ Investor Presentation 25
Slide 26: Blue Cap on the Stock Market: Share Price at All-Time High
Blue Cap on the Stock Market: Share Price at All-Time High Reference Data Positive Recommendations by Analysts ▪ ISIN/WKN: DE 00A0JM2M1 / A0J M2M Target ▪ Ticker: B7E Institution Date Rating Price ▪ Share Capital: 4,396,290.00 Euro / 4,396,290 pcs M.M. Warburg 09.08.2021 Buy 42.00 € ▪ Market Segment
Slide 27: Half Year 2021 - Segment Performance
Half Year 2021 - Segment Performance Revenue by Segment EBITDA Margin (adj.) by Segment In EUR mn In % Plastics Technology 64.1 Plastics Technology 11.0 H1 2021 48.1 5.1 H1 2020 25.4 7.1 Coating Technology 26.3 Coating Technology 9.1 Adhesive Technology 17.5 Adhesive Technology 10.2 14.7 4.8 1.8 -55
Slide 28: Sustainability at Blue Cap: Our Roadmap to Anchor an ESG Strategy
Sustainability at Blue Cap: Our Roadmap to Anchor an ESG Strategy at Group Level 2020 ✓ 2021 2022 2023ff ▪ ESG project: kick off at Blue ▪ Dedicated ESG chapter ▪ Publication of first ESG ▪ ESG rating ✓ Cap holding in annual report 2020 report (DNK basis (2)) ▪ ESG linked „Green Financing“ ▪ Sensiti
Slide 29: Disclaimer
Disclaimer By accessing this document, you acknowledge the restrictions on use set out Insofar as the information contained in this document is based on statements herein. The information contained in this document regarding Blue Cap AG made by third parties, we would like to point out that no warra